Earth Science Tech (ETST) Return on Capital Employed (2012 - 2026)
Earth Science Tech's (ETST) quarterly Return on Capital Employed came in at 50.12% in Q1 2026, down 5626.0% YoY from 0.91% in Q1 2025, and down 12.21% on a QoQ basis from 57.1% in Q4 2025.
Earth Science Tech (ETST) Return on Capital Employed (2012 - 2026) Analysis & Trends
Earth Science Tech (ETST) has 13 years of Return on Capital Employed data on file, last reported at 50.12% in Q1 2026.
- Quarterly Return on Capital Employed fell 5626.0% year-over-year to 50.12% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 50.12% (down 5626.0% YoY) and the FY2026 annual result came in at 54.33%, down 9379.0% from the prior year.
- Return on Capital Employed retreated to 50.12% in Q1 2026, from 57.1% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 106.38% in Q1 2025 to a low of 287.87% in Q1 2023.
- A 5-year average of 30.93% and a median of 50.12% in 2026 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed sank 30025 bps — and 2024, when it surged 33302 bps.
- Tracing ETST's Return on Capital Employed over 5 years: stood at 92.12% in 2022, then slumped by 74 bps to 24.13% in 2023, then soared by 222 bps to 77.65% in 2024, then dropped by 26 bps to 57.1% in 2025, then slipped by 12 bps to 50.12% in 2026.
- The last three Return on Capital Employed figures came in at 50.12% (Q1 2026), 57.1% (Q4 2025), and 50.9% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Earth Science Tech | 35.67 Mn | 32.85 Mn | 6.28 Mn | 53.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 53.59% |
| Mar 31, 2026 | 50.12% |
| Dec 31, 2025 | 57.10% |
| Sep 30, 2025 | 50.90% |
| Jun 30, 2025 | 65.19% |
| Mar 31, 2025 | 106.38% |
| Dec 31, 2024 | 77.65% |
| Sep 30, 2024 | 74.23% |
| Jun 30, 2024 | 71.55% |
| Mar 31, 2024 | 45.15% |
| Dec 31, 2023 | 24.13% |
| Sep 30, 2023 | 11.56% |
| Jun 30, 2023 | -14.27% |
| Mar 31, 2023 | -287.87% |
| Dec 31, 2022 | 92.12% |
| Sep 30, 2022 | 45.86% |
| Jun 30, 2022 | 43.58% |
| Mar 31, 2022 | 12.38% |
| Dec 31, 2021 | 19.71% |
| Sep 30, 2021 | 19.53% |